Fierce Biotech Week 2026
Everett, MA
Event summary
Cooley is a proud sponsor of Fierce Biotech Week, which brings together executive leaders from biotech, pharma and the investment community to tackle today’s most urgent challenges and unlock tomorrow’s breakthroughs through scientific innovation, strategic clarity and smart capital.
Featured agenda item
Wednesday, May 13, 2026 | 2:10 – 2:50 pm
Going Public in 2026: The New Biotech Playbook
Cooley partner Eric Blanchard will speak on this panel covering:
- How biotech companies are navigating today’s IPO market.
- The rise of reverse mergers and special purpose acquisition companies as alternative routes to access public capital.
- What investors are looking for today – from valuation expectations to stage of entry.
- How capital is being recycled across the ecosystem and what that means for emerging biotech companies.
- Real-world insights on structuring deals and choosing the right path to go public in a shifting market.
For more information, please email Alia Holness.
Related Contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.